Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation

Leukemia. 2003 Apr;17(4):811-3. doi: 10.1038/sj.leu.2402867.

Authors

C Chabannon, A-G Le Corroller, F Viret, C Eillen, C Faucher, J-P Moatti, P Viens, N Vey, A-C Braud, G Novakovitch, P Ladaique, A-M Stoppa, J Camerlo, D Genre, D Maraninchi, D Blaise

PMID: 12682645
DOI: 10.1038/sj.leu.2402867

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Blood Cell Count
Blood Component Removal / economics*
Cohort Studies
Combined Modality Therapy
Cost-Benefit Analysis
Female
Filgrastim
Graft Survival
Granulocyte Colony-Stimulating Factor / pharmacology
Hematopoietic Stem Cell Mobilization / economics*
Hematopoietic Stem Cell Mobilization / methods
Humans
Male
Middle Aged
Neoplasms / blood
Neoplasms / drug therapy
Neoplasms / therapy
Peripheral Blood Stem Cell Transplantation / economics*
Recombinant Proteins
Retrospective Studies
Transplantation, Autologous

Substances

Recombinant Proteins
Granulocyte Colony-Stimulating Factor
Filgrastim